'Turning Science into Business' AI & ML summit: Navigating AI-driven drug discovery

Hosted by Drug Discovery World and sponsored by The Jackson Laboratory, the DDW ‘Turning Science into Business’ AI & ML Summit: Navigating AI-driven Drug Discovery spotlights groundbreaking innovations in AI-powered drug discovery.

Co-founder and CEO of Anima Biotech, Yochi Slonim is speaking about Lightning.AI, our platform where two AI agents work in a continuous loop, that leverages Visual Biology approach to reshape target and drug discovery.

Joining him are Mark Hammond, Founding Director at Deep Science Ventures, and Tyrone Lam, Chief Operating Officer at GATC Health, who will offer additional insights into AI’s expanding role in drug discovery.

A panel discussion explores how AI is addressing unmet needs, optimizing drug discovery, and unlocking future possibilities in pharmaceutical research.